Care Rail

← Medical · All 20 for Interstitial lung disease

Japan

Interstitial lung disease · Respiratory

High visit frequency, low unit prices, specialist access without US-style referral walls. Respiratory pathway via Statutory insurance, fee schedule.

Rank in this country#33
Share of deaths0.8%
Master rank#34
System quality rank#3

Access & coverage

Statutory insurance, fee schedule

Statutory insurance + national fee schedule; almost universal access

Treatment

  • Inhaled bronchodilators / steroids per phenotype
  • Oxygen / NIV for advanced disease
  • Exacerbation pathways and hospital-at-home where available

Prevention

  • Tobacco control; clean air / occupational dust rules
  • Vaccination (flu, pneumococcal, COVID) for high-risk groups
  • Early COPD case-finding in smokers

Lifestyle

  • Smoking cessation is the dominant lever
  • Pulmonary rehab exercise + breathing training
  • Avoid indoor smoke and occupational triggers

What stands out here

Same broad respiratory toolkit as peers — differences are coverage rules, wait times, prices, and follow-through.

vs master: +0.0 percentage points vs Top 20 average share.